|
GNA12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56479999996662E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16900000002307E-06 |
| Normal-vs-Stage2 |
7.581600E-01 |
| Normal-vs-Stage3 |
1.821730E-02 |
| Normal-vs-Stage4 |
1.057910E-02 |
| Stage1-vs-Stage2 |
1.291620E-02 |
| Stage1-vs-Stage3 |
2.067800E-01 |
| Stage1-vs-Stage4 |
5.874200E-01 |
| Stage2-vs-Stage3 |
1.896620E-01 |
| Stage2-vs-Stage4 |
4.579500E-02 |
| Stage3-vs-Stage4 |
2.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53378999999676E-05 |
| Normal-vs-AfricanAmerican |
5.768200E-02 |
| Normal-vs-Asian |
2.625000E-01 |
| Caucasian-vs-AfricanAmerican |
7.690600E-01 |
| Caucasian-vs-Asian |
9.794400E-01 |
| AfricanAmerican-vs-Asian |
8.871800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.95230000000058E-05 |
| Normal-vs-Female |
2.775800E-04 |
| Male-vs-Female |
8.488600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.212200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.38179999999533E-05 |
| Normal-vs-Age(61-80Yrs) |
1.000450E-03 |
| Normal-vs-Age(81-100Yrs) |
8.776000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.406200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.642840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.597900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.865010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.078400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.455030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.281300E-03 |
| Normal-vs-Grade 2 |
7.76300000000507E-05 |
| Normal-vs-Grade 3 |
2.845900E-02 |
| Normal-vs-Grade 4 |
5.814700E-04 |
| Grade 1-vs-Grade 2 |
1.337360E-01 |
| Grade 1-vs-Grade 3 |
3.482000E-02 |
| Grade 1-vs-Grade 4 |
8.667400E-01 |
| Grade 2-vs-Grade 3 |
1.014170E-01 |
| Grade 2-vs-Grade 4 |
7.706000E-02 |
| Grade 3-vs-Grade 4 |
1.244150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.667970E-02 |
| Normal-vs-ccB subtype |
1.95410000003449E-06 |
| ccA subtype-vs-ccB subtype |
3.984600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.382700E-04 |
| Normal-vs-N1 |
6.303700E-02 |
| N0-vs-N1 |
1.329410E-01 |
|
|
